KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal

KOASurface Area (m2)Blood priming Volume (ml)Clearances at QB 200/300 (ml/min)UF Coefficient (Ultrafiltration)(ml/mmHg.h)Type
InulinVitamine B12PhosphateCreatinineUrea
6371.059-73/78140/158164/196183/2316.8PS 10 LF
7461.369-86/93150/178176/218191/2438.8PS 13 LF
10641.686-111/125161/192184/237195/26612.9PS 16 LF
12921.8105-129/144171/211188/259197/27615.5PS 18 LF
5181.059-91/99134/154155/185171/2148.4PES 10 LF
6291.371-108/121149/176169/207181/23010.4PES 13 LF
7571.690-117/131158/188178/224188/24412.1PES 16 LF
11231.8112-124/141168/208183/252196/26917PES 18 LF
 

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min,  T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

 

Undulation

 

 

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

  • Increases clearance values
  • Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

  • Thicker separation layer
  • Unchanged ultrafiltration
  • More uniform pore distribution
  • Active surface management

Steeper sieving curve

More selective removal